Get the Daily Brief
Latest Biotech News
Biopharma Financing Trends and Industry Movements
The biopharmaceutical sector reflects dynamic shifts in financing and corporate strategies. Venture funding for PD-1 and VEGF modalities grows amid capital shortcomings in other areas. Public and...
FDA Curbs Bluebird Gene Therapy Over Cancer Risks
The U.S. Food and Drug Administration has imposed restrictions on bluebird bio’s gene therapy Skysona, used for a rare neurological disorder, after clinical trials showed a substantial increase in...
AI and Machine Learning Revolutionize Biotech Research Tools
Recent breakthroughs in artificial intelligence and machine learning are advancing biotech research efficiency and precision. Biotechnology firms have harnessed AI for designing protein structures...
mRNA Patent Settlement Advances BioNTech Acquisition Plans
BioNTech has resolved a longstanding patent dispute with CureVac and GSK through a $740 million settlement plus royalty payments. This agreement clears a significant hurdle for BioNTech's ongoing...
Pharma Fluctuations: Financing, Layoffs, and Launches Mark 2025
The biotech and pharmaceutical industries have experienced substantial financial maneuvers and workforce adjustments in mid-2025. Notable is Frazier Life Sciences’ closing of a $1.3 billion fund...
Novel Therapeutics and Diagnostics Drive Oncology Advancements
Cancer research continues to progress with promising new treatments and diagnostic tools. Senhwa Biosciences received U.S. NCI sponsorship for a program targeting MYC-aberrant lymphoma, while...
Regulatory Developments: FDA Actions and Industry Impact
Regulatory events continue to shape biotech and pharmaceutical developments. The FDA approved Boehringer Ingelheim’s targeted pill zongertinib for HER2-mutated lung cancer, advancing options for...
HHS Cuts $500M in mRNA Vaccine Funding Spark Backlash
The U.S. Department of Health and Human Services announced termination of nearly $500 million in funding for mRNA vaccine research under BARDA, spearheaded by Secretary Robert F. Kennedy Jr....
Advances in Pediatric and Neonatal Medical Imaging
Innovations in pediatric imaging are improving diagnosis and treatment across diverse conditions. Deep learning methods have enhanced MRI image quality in children, minimizing sedation needs....
Strand Therapeutics Raises $153M for Programmable mRNA Cancer Drugs
MIT spinout Strand Therapeutics secured $153 million in Series B funding led by Kinnevik to progress its innovative programmable mRNA therapies aimed at expressing cytokines like IL-12 within...
Eli Lilly’s Oral Obesity Pill Results Moderate Compared to Injectables
Eli Lilly’s experimental oral GLP-1 receptor agonist, orforglipron, demonstrated 11.2% mean weight loss over 72 weeks in late-stage trials, falling short of higher efficacy rates observed with...
FDA Internal Struggles and Procedural Transparency Concerns
Recent events at the U.S. Food and Drug Administration (FDA) have brought attention to internal operational challenges and questions over regulatory decision-making processes. In a town hall...
mRNA Vaccine Funding Cuts and National Security Implications
The U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr., has ceased nearly $500 million in funding for mRNA vaccine development through the Biomedical...
Advances in Protein Evolution Techniques
A transformative platform named T7-ORACLE has been developed by researchers at Scripps Research Institute to accelerate directed protein evolution inside living cells. Leveraging an orthogonal T7...
Biopharma Financing Trends and Industry Fundraising
Biopharmaceutical fundraising in 2025 shows a nuanced landscape characterized by a total of approximately $34.89 billion raised through various financing mechanisms in the first seven months,...
New Clinical Approvals and Regulatory Updates in Oncology and Infectious Diseases
Recent regulatory developments have advanced therapeutic options in oncology and infectious diseases. The FDA has granted accelerated approval to Boehringer Ingelheim’s oral targeted therapy...
Innovations in Hydrogel and Biomaterial Design
Cutting-edge research leverages artificial intelligence and bioinspiration to engineer advanced hydrogels with superior adhesive properties. Inspired by marine organisms such as barnacles and...
Neurodegenerative Disease Research Advances
Recent breakthroughs illuminate pivotal mechanisms and potential therapies targeting neurodegenerative disorders. Harvard Medical School researchers demonstrated reversal of Alzheimer's pathology...
AI and Computational Innovations in Single-Cell and Genomic Analysis
Significant technological advancements have been achieved in the integration of artificial intelligence with genomics and single-cell biology. 10x Genomics announced the acquisition of Scale...
Obesity and Metabolic Disease Therapeutics Landscape
The competitive landscape for obesity treatments evolves amid mixed clinical results and market dynamics. Eli Lilly's oral GLP-1 agonist, orforglipron, demonstrated weight loss efficacy up to...